{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:30:53Z","timestamp":1793374253051,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-024-06203-2","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T15:04:34Z","timestamp":1730127874000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Ketamine and chronic treatment-resistant depression: real-world practice and after relapse"],"prefix":"10.1186","volume":"24","author":[{"given":"Sumaya","family":"Jobnah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef","family":"Latifeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Al Kabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lama A.","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"key":"6203_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2017-017173","volume":"7","author":"J Wang","year":"2017","unstructured":"Wang J, Wu X, Lai W, Long E, Zhang X, Li W, et al. Prevalence of depression and depressive symptoms among outpatients: a systematic review and meta-analysis. BMJ Open. 2017;7:1\u201314.","journal-title":"BMJ Open"},{"key":"6203_CR2","doi-asserted-by":"crossref","unstructured":"Sarawagi A, Soni ND, Patel AB, Glutamate, Homeostasis GABA. and Neurometabolism in Major Depressive Disorder.\u00a0Front Psychiatry. 2021;12:637863.","DOI":"10.3389\/fpsyt.2021.637863"},{"issue":"1","key":"6203_CR3","first-page":"55","volume":"358","author":"C Otte","year":"2008","unstructured":"Otte C, Gold S, Penninx B, Pariante C. Major depressive disorder (invited review). Nat Rev Dis. 2008;358(1):55\u201368 Available from: www.nejm.org.","journal-title":"Nat Rev Dis"},{"key":"6203_CR4","first-page":"766","volume":"111","author":"T Bschor","year":"2014","unstructured":"Bschor T, Bauer M, Adli M. Chronic and treatment resistant depression - diagnosis and stepwise therapy. Deutsches Arzteblatt Int. 2014;111:766\u201376.","journal-title":"Deutsches Arzteblatt Int"},{"issue":"6","key":"6203_CR5","first-page":"785","volume":"77","author":"SM Adams","year":"2008","unstructured":"Adams SM, Miller KE, Zylstra RG. Pharmacologic management of adult depression. Am Fam Physician. 2008;77(6):785\u201392.","journal-title":"Am Fam Physician"},{"key":"6203_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/da.22968","volume":"37","author":"BN Gaynes","year":"2020","unstructured":"Gaynes BN, Lux L, Gartlehner G, Asher G, Forman-Hoffman V, Green J, et al. Defining treatment-resistant depression. Depress Anxiety. 2020;37:134\u201345.","journal-title":"Depress Anxiety"},{"key":"6203_CR7","doi-asserted-by":"publisher","first-page":"S281","DOI":"10.1016\/j.euroneuro.2021.10.364","volume":"53","author":"AI De Santiago-D\u00edaz","year":"2021","unstructured":"De Santiago-D\u00edaz AI, G\u00f3mez-Revuelta M, Sastre-Ya\u00f1ez J, G\u00f3mez-Ruiz E, Artal-Sim\u00f3n J. P.0391 Ultra-resistant major depression: treatment with in-esketamine on compassionate use. Eur Neuropsychopharmacol. 2021;53:S281.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"10","key":"6203_CR8","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1177\/0269881118793104","volume":"32","author":"RK Thomas","year":"2018","unstructured":"Thomas RK, Baker G, Lind J, Dursun S. Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity as clinical predictors of effectiveness. J Psychopharmacol. 2018;32(10):1110\u20137.","journal-title":"J Psychopharmacol"},{"key":"6203_CR9","doi-asserted-by":"crossref","unstructured":"M.T. B, G. T. Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Can J Psychiatry. 2007;52(1):46\u201354. Available from: http:\/\/www.embase.com\/search\/results?subaction=viewrecord&from=export&id=L46743497%5Cnhttp:\/\/publications.cpa-apc.org\/media.php?mid=322","DOI":"10.1177\/070674370705200108"},{"key":"6203_CR10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2147\/PPA.S29716","volume":"6","author":"KS Al-Harbi","year":"2012","unstructured":"Al-Harbi KS. Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient Prefer Adherence. 2012;6:369\u201388.","journal-title":"Patient Prefer Adherence"},{"key":"6203_CR11","doi-asserted-by":"crossref","unstructured":"Berman RM Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH CA, Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47(4):351. Available from: http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=med4&NEWS=N&AN=10686270%0A. http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=cctr&NEWS=N&AN=CN-00275466","DOI":"10.1016\/S0006-3223(99)00230-9"},{"issue":"8","key":"6203_CR12","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate","year":"2006","unstructured":"Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63(8):856\u201364.","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"6203_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/0004867416631828","volume":"51","author":"C Cusin","year":"2017","unstructured":"Cusin C, Ionescu DF, Pavone KJ, Akeju O, Cassano P, Taylor N, et al. Ketamine augmentation for outpatients with treatment-resistant depression: preliminary evidence for two-step intravenous dose escalation. Aust N Z J Psychiatry. 2017;51(1):55\u201364.","journal-title":"Aust N Z J Psychiatry"},{"issue":"7","key":"6203_CR14","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41380-018-0256-5","volume":"25","author":"M Fava","year":"2020","unstructured":"Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, et al. Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). Mol Psychiatry. 2020;25(7):1592\u2013603.","journal-title":"Mol Psychiatry"},{"issue":"4","key":"6203_CR15","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","volume":"74","author":"JW Murrough","year":"2013","unstructured":"Murrough JW, Perez AM, Pillemer S, Stern J, Parides MK, Aan Het Rot M, et al. Rapid and longer-term antidepressant effects of A ketamine infusions in treatment-resistant major depression. Biol Psychiatry. 2013;74(4):250\u20136. https:\/\/doi.org\/10.1016\/j.biopsych.2012.06.022.","journal-title":"Biol Psychiatry"},{"key":"6203_CR16","doi-asserted-by":"crossref","unstructured":"Singh JB, Fedgchin M, Daly EJ, Boer P De, Cooper K, Lim P, et al. A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression. Am J Psychiatry. 2016;173:816\u201326.","DOI":"10.1176\/appi.ajp.2016.16010037"},{"issue":"3","key":"6203_CR17","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.117.015198","volume":"70","author":"P Zanos","year":"2018","unstructured":"Zanos P, Moaddel R, Morris PJ, Riggs LM, Highland JN, Georgiou P, et al. Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms. Pharmacol Rev. 2018;70(3):621\u201360.","journal-title":"Pharmacol Rev"},{"key":"6203_CR18","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jad.2020.09.007","volume":"277","author":"WS Marcantoni","year":"2020","unstructured":"Marcantoni WS, Akoumba BS, Wassef M, Mayrand J, Lai H, Richard-Devantoy S, et al. A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 \u2013 January 2019. J Affect Disord. 2020;277:831\u201341.","journal-title":"J Affect Disord"},{"key":"6203_CR19","unstructured":"GBD. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019; Seattle: Institute of Health Metrics and Evaluation (IHME). 2020. 2019. VizHub - GBD Results."},{"issue":"906","key":"6203_CR20","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1017\/S1816383119000080","volume":"99","author":"M Hedar","year":"2017","unstructured":"Hedar M. Mental health during the Syrian crisis: how syrians are dealing with the psychological effects. Int Rev Red Cross. 2017;99(906):927\u201335.","journal-title":"Int Rev Red Cross"},{"issue":"3","key":"6203_CR21","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.1192\/bji.2021.16","volume":"18","author":"F Mohsen","year":"2021","unstructured":"Mohsen F, Bakkar B, Melhem S, Aldakkak S, Mchantaf D, Marrawi M, et al. Psychological health problems among syrians during war and the COVID-19 pandemic: national survey. BJPsych Int. 2021;18(3):E8.","journal-title":"BJPsych Int"},{"key":"6203_CR22","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.). 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"4","key":"6203_CR23","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134(4):382\u20139.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"6203_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1023\/A:1024465317902","volume":"11","author":"JD Bremner","year":"1998","unstructured":"Bremner JD, Krystal JH, Putnam FW, Southwick SM, Marmar C, Charney DS, et al. Measurement of dissociative states with the clinician-administered dissociative states scale (CADSS). J Trauma Stress. 1998;11(1):125\u201336.","journal-title":"J Trauma Stress"},{"issue":"3","key":"6203_CR25","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","volume":"10","author":"JE Overall","year":"1962","unstructured":"Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep. 1962;10(3):799\u2013812.","journal-title":"Psychol Rep"},{"issue":"10194","key":"6203_CR26","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0140-6736(19)30934-1","volume":"394","author":"F Charlson","year":"2019","unstructured":"Charlson F, van Ommeren M, Flaxman A, Cornett J, Whiteford H, Saxena S. New WHO prevalence estimates of mental disorders in conflict settings: a systematic review and meta-analysis. Lancet. 2019;394(10194):240\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(19)30934-1.","journal-title":"Lancet"},{"issue":"S1","key":"6203_CR27","doi-asserted-by":"publisher","first-page":"S261","DOI":"10.1192\/bjo.2021.696","volume":"7","author":"S Jomaa","year":"2021","unstructured":"Jomaa S, Kakaje A, Al Zohbi R, Aldeen OH, Makki L, Alyousbashi A, et al. Mental Disorder and PTSD in Syria during wartime: a nationwide crisis. BJPsych Open. 2021;7(S1):S261\u2013261.","journal-title":"BJPsych Open"},{"key":"6203_CR28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1176\/appi.ajp.2021.21050535","volume":"179","author":"JC Markowitz","year":"2021","unstructured":"Markowitz JC, Wright JH, Peeters F, Thase ME, Kocsis JH, Sudak DM. The neglected role of psychotherapy for treatment-resistant depression. Am J Psychiatry. 2021;179:90\u20133.","journal-title":"Am J Psychiatry"},{"key":"6203_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jad.2013.10.036","volume":"155","author":"PR Shiroma","year":"2014","unstructured":"Shiroma PR, Johns B, Kuskowski M, Wels J, Thuras P, Albott CS, et al. Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression. J Affect Disord. 2014;155:123\u20139.","journal-title":"J Affect Disord"},{"key":"6203_CR30","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.biopsych.2009.08.038","volume":"67","author":"M ann het Rot","year":"2009","unstructured":"ann het Rot M, Collins KA, Murrough JW, Perez AM, Reich DL, Charney DS, Mathew SJ. Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biol Psychiatry. 2009;67:139\u201345.","journal-title":"Biol Psychiatry"},{"key":"6203_CR31","first-page":"6","volume":"2013","author":"N Wiles","year":"2013","unstructured":"Wiles N, Williams CJ, Kessler D, Lewis G. Psychological therapies for treatment-resistant depression in adults. Cochrane Database Syst Rev. 2013;2013:6.","journal-title":"Cochrane Database Syst Rev"},{"key":"6203_CR32","doi-asserted-by":"publisher","unstructured":"Rush JA, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D et al. Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report. Am J Psychiatry [Internet]. 2006;163(11):1905\u201317. http:\/\/ajp.psychiatryonline.org.proxy.hsl.ucdenver.edu\/doi\/pdf\/https:\/\/doi.org\/10.1176\/ajp.2006.163.11.1905","DOI":"10.1176\/ajp.2006.163.11.1905"},{"key":"6203_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jpsychires.2018.09.013","volume":"106","author":"W Zheng","year":"2018","unstructured":"Zheng W, Zhou YL, Liu WJ, Wang CY, Zhan YN, Li HQ, et al. Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression. J Psychiatr Res. 2018;106:61\u20138.","journal-title":"J Psychiatr Res"},{"issue":"5","key":"6203_CR34","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1177\/0269881113478283","volume":"27","author":"KG Rasmussen","year":"2013","unstructured":"Rasmussen KG, Lineberry TW, Galardy CW, Kung S, Lapid MI, Palmer BA, et al. Serial infusions of low-dose ketamine for major depression. J Psychopharmacol. 2013;27(5):444\u201350.","journal-title":"J Psychopharmacol"},{"issue":"2","key":"6203_CR35","doi-asserted-by":"publisher","first-page":"158","DOI":"10.55229\/ijbs.v25i2.14","volume":"25","author":"S Akanksha","year":"2022","unstructured":"Akanksha S, Kumar VP, Gupta, Rehan Mateen SAA. Intravenous ketamine-induced affective switch in a patient of major depressive disorder with suicidal ideation: a case report. Indian J Behav Sci. 2022;25(2):158\u201360.","journal-title":"Indian J Behav Sci"},{"key":"6203_CR36","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1016\/j.biopsych.2015.07.003","volume":"79","author":"L Alison McInnes","year":"2016","unstructured":"Alison McInnes L, James-Myers MB, Turner MS. Possible affective switch associated with Intravenous ketamine treatment in a patient with bipolar I disorder. Biol Psychiatry. 2016;79:e71-2.","journal-title":"Biol Psychiatry"},{"key":"6203_CR37","doi-asserted-by":"publisher","first-page":"454","DOI":"10.4103\/0253-7613.161277","volume":"47","author":"G Banwari","year":"2015","unstructured":"Banwari G, Desai P, Patidar P. Ketamine-induced affective switch in a patient with treatment-resistant depression. Indian J Pharmacol. 2015;47:454\u20135.","journal-title":"Indian J Pharmacol"},{"key":"6203_CR38","doi-asserted-by":"crossref","unstructured":"Lu YY, Lin CH, Lane HY. Mania following ketamine abuse. Neuropsychiatr Dis Treat. 2016;12:237\u20139.","DOI":"10.2147\/NDT.S97696"},{"key":"6203_CR39","doi-asserted-by":"crossref","unstructured":"Mandyam MC, Ahuja NK. Ketamine-induced mania during treatment for complex regional pain syndrome. Pain Med (United States). 2017;18:2040\u20131.","DOI":"10.1093\/pm\/pnx061"},{"key":"6203_CR40","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1176\/appi.neuropsych.15040091","volume":"28","author":"CJ Marta","year":"2016","unstructured":"Marta CJ, Yudofsky LM, Enenbach MJ. Probable ketamine-induced hypomanic-like episode in a child with cerebral palsy. J Neuropsychiatry Clin Neurosci. 2016;28:e6-7.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"5","key":"6203_CR41","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.psym.2016.06.003","volume":"57","author":"SD Nichols","year":"2016","unstructured":"Nichols SD, Bulman M, Tisher A, Campbell JJ. A case of possible iatrogenic ketamine-Induced Mania in a patient being treated for postoperative pain. Psychosomatics. 2016;57(5):543\u20136.","journal-title":"Psychosomatics"},{"key":"6203_CR42","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.biopsych.2011.02.030","volume":"70","author":"AK Ricke","year":"2011","unstructured":"Ricke AK, Snook RJ, Anand A. Induction of prolonged mania during ketamine therapy for reflex sympathetic dystrophy. Biol Psychiatry. 2011;70:e13.","journal-title":"Biol Psychiatry"},{"key":"6203_CR43","doi-asserted-by":"crossref","unstructured":"Wilkowska A, Sza\u0142ach \u0141, S\u0142upski J, Wielewicka A, Czarnota M, Ga\u0142uszko-W\u0119gielnik M, et al. Affective switch Associated with oral, low dose ketamine treatment in a patient with treatment resistant bipolar I Depression. Case Report and Literature Review. Front Psychiatry. 2020;11:516.","DOI":"10.3389\/fpsyt.2020.00516"},{"key":"6203_CR44","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1503\/jpn.190073","volume":"44","author":"J Talbot","year":"2019","unstructured":"Talbot J, Phillips JL, Blier P. Ketamine for chronic depression: two cautionary tales. J Psychiatry Neurosci. 2019;44:384\u20135.","journal-title":"J Psychiatry Neurosci"},{"key":"6203_CR45","doi-asserted-by":"publisher","first-page":"S411","DOI":"10.1016\/S0924-977X(13)70651-5","volume":"23","author":"JW Murrough","year":"2013","unstructured":"Murrough JW, Iosifescu DV, Chang L, Al Jurdi RK, Green C, Perez A, et al. P.2.f.028 antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site, randomised controlled trial. Eur Neuropsychopharmacol. 2013;23:S411-2.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"9","key":"6203_CR46","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1001\/archpsyc.62.9.985","volume":"62","author":"JH Krystal","year":"2005","unstructured":"Krystal JH, Perry EB, Gueorguieva R, Belger A, Madonick SH, Abi-Dargham A, et al. Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine. Arch Gen Psychiatry. 2005;62(9):985.","journal-title":"Arch Gen Psychiatry"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-06203-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-024-06203-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-06203-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T15:06:02Z","timestamp":1730127962000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-024-06203-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6203"],"URL":"https:\/\/doi.org\/10.1186\/s12888-024-06203-2","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]},"assertion":[{"value":"30 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Scientific Research Ethics Committee at the faculty of pharmacy, Damascus university, and all eligible patients gave their signed informed consent at the enrolment point.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"745"}}